Wednesday, March 20, 2013

Jerome Karam

Check out the latest articles and news stories for Jerome Karam:

http://www.emailwire.com/release/102748-Friendswood-Lawyer-and-Property-Developer-Jerome-Karam-Works-hard-to-enhance-his-Community.html

http://finance.yahoo.com/news/jerome-karam-talks-plaza-28-195101702.html

For more information check out the developments and help you can receive for your case with Jerome Karam.

Thanks to great innovations and building permits being approved Plaza 28 has now broken ground and is being developed in Louisana. With great anticipation the world is excited with resounding success about the potential that this new property has. Please stay tuned for the latest news and updates on the property that will be broadcasted live here on the blog. 

Saturday, January 19, 2013

Dr. Brady Frank – Dental Implants Made Easy brady frank dentist ashland


The prospect of going to the dentist for a dental implantation procedure can leave your
stomach in knots. Admittedly, no one will be jumping for joy after learning they need any
sort of procedure, but thanks to Dr. Brady Frank’s No-Drill Implant Technique, securing
a healthy smile has never been easier.

Dr. Frank’s technique is relatively new to the community, but legend of his two-day mini
residencies and boot camps is quickly spreading throughout the nation. Dentists are lining
up in droves to learn from the master himself, so that they can incorporate his pioneering
techniques into their home practices. In fact, it is proven that any dentist who trains under
Dr. Frank’s tutelage is guaranteed to grow his or her practice by a staggering 26% or
more during the first year.

Is that even possible? The answer is a resounding yes. Dr. Frank is not only a highly
regarded dentist; he’s also a savvy entrepreneur and active real estate investor. This
means that he’ll be able to teach his students the steps towards making their practice
more visible and enticing to the public. With greater visibility, come more patients, and
more yearly revenue. It’s really that simple.

All of Dr. Brady Frank’s training is hands-on. No longer will dentists have to study
techniques via a textbook or a drawn out lecture. Instead, Dr. Frank will personally guide
his students through a multitude of different scenarios, proving each time that the No-
Drill Implant technique works no matter how severe the case.

To make things even better, the technique can be completed in one visit, without the
use of complicated tools, and at minimal discomfort to the patient. Imagine the freedom
associated by not having to spend multiple sessions on one patient. Better yet, imagine
how happy patients will be when they can go back to work the very same day, pain free
and cured. This is the unique opportunity afforded to dentists who take a few days out of
their busy schedule to train with Dr. Brady Frank.

Tuesday, January 8, 2013

Latest FRET Process information

Förster (or fluorescence) resonance energy transfer (FRET) is a process involving the radiation-less transfer of energy from a "donor" fluorophore to an "acceptor" fluorophore. FRET technology enables the quantitative analysis of molecular dynamics in biophysics and in molecular biology, such as the monitoring of protein-protein interactions, protein-DNA interactions, and protein conformational changes. FRET-based biosensors have been utilized to monitor cellular dynamics not only in heterogeneous cellular populations, but also at the single-cell level in real time. Lately, applications of FRET-based biosensors range from basic biological to biomedical disciplines. Despite the diverse applications of FRET, FRET-based sensors still face many challenges. There is an increasing need for higher fluorescence resolution and improved specificity of FRET biosensors. Additionally, as more FRET-based technologies extend to medical diagnostics, the affordability of FRET reagents becomes a significant concern. Here, we will review current advances and limitations of FRET-based biosensor technology and discuss future FRET applications.

Wednesday, December 12, 2012

Sohila Zadran

Dr. Sohila Zadran was recently featured in Yahoo! Finance, Reuters, Marketwatch, and numerous other news & media publications for her extensive research work and what it has done for the overall morale of UCLA students at the Geffen School of Medicine.

With rough economic times in the educational system it is tough for students to find a direction if they are not getting paid but Sohila is helping students to work for a greater cause and helping them to realize the big picture. 

Wednesday, November 7, 2012

Sohila Zadran Overview

Sohila Zadran's Resume and Overview:
Education
California Institute of Technology
University of Southern California
University of California, Berkeley
Connections
460 connections
Sohila Zadran's Organizations
United Nations High Commissioner for Refugees
Emphasis: Afghanistan
Society for Neuroscience (SfN)
Emphasis: Biotechnology
American Association for Cancer Research (AACR)
Emphasis: Biotechnology and Neuro-Oncology
Rosalind Franklin Society
Member
Association for Women in Science (AWIS)
Member

Monday, October 29, 2012

Agarionan - California Institute for QB3

Agarionan now a member of California Institute for Quantitative Biosciences (QB3)!
Dr. Sohila Zadran established Agarionan in 2012 and has now become a part of the California Institute for Quantitative Biosciences (QB3). Agarionan is the next-generation cancer diagnostics market.  The total global annual market for next-generation cancer diagnostics was $750 million in 2010, and is growing at a compound annual growth rate (CAGR) of 47%, to reach a market size of $5.3 billion in 2015. Unlike other cancer detection modules currently in the market, our system applies a first-in-the field information-theoretical technique to identify cancer-specific signatures and develop predictive formulations to determine how patient-specific response to therapeutics.  Agarionan’s technology not only demonstrates great accuracy, distinguish healthy and diseased states, but is also economical. Production of the MB-based chips costs less than a fraction of a percent of current micro-fluidic modules in the market.  Agarionan is currently in the process of acquiring Start-Up Funding and Seed-Stage Funding for further development of the technology and to establish an effective and cross-functional management team.  We anticipate these chips to be available to the market by Spring 2014.

Wednesday, September 12, 2012

Sohila Zadran Caltech

Update on Tumefaction Biology. From Doctor Sohila Zadran of UCLA.
Gliomablastoma multiform (GBM) may be the many intense of mind malignancies in people. Reaction to present treatments stays excessively bad, with depressing success data. an essential component in the AKT/PI3K/PTEN regulating cycle, with the capacity of synergizing melanoma cell expansion and cardiovascular glycolysis in vitro lately, the ER UDPase, ENTPD5 was identified. Employing a book Enhanced Acceptor Fluorescence (EAF )-based solitary mobile ATP biosensor, Dr. Zadran examined ENTPD5-mediated modulation of cytosolic ATP. ENTPD5-dependent modulation of mobile ATP in GBM outcomes in changed metabolic kinetics in vitro, growing both the catabolic effectiveness of both cardiovascular glycolysis and of fatty acid oxidation. In addition, an of ENTPD5 in GBM individual growths and in both GBM mouse xenografts was recognized, leading to significantly paid off success. Consequently, these outcomes not just supply fresh resources to check mobile kcalorie burning kinetics and ATP flux, but additionally recognized a book healing goal for GBM.